RLAY - Relay Therapeutics GAAP EPS of -$0.54 revenue of $25.2M November, 03 2023 01:07 AM Relay Therapeutics Inc. 2023-11-03 01:07:35 ET More on Relay Therapeutics Relay Therapeutics surges 13% on early-stage data on tumors asset Seeking Alpha’s Quant Rating on Relay Therapeutics For further details see: Relay Therapeutics GAAP EPS of -$0.54, revenue of $25.2M